| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |